Medical comms - Press Releases

Date	Title	Company
16-Dec-2020	Conference Chair from Johnson & Johnson invites you to attend Pre-filled Syringes East Coast 2021	SMi Group Ltd
16-Dec-2020	Exclusive Interview: Julian Bahr, Postdoctoral Fellow at AstraZeneca and speaker at 3D Cell Culture Conference	SMi Group
16-Dec-2020	Blocking DNA repair enzyme could help treat certain cancers	The Francis Crick Institute
16-Dec-2020	Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF	Novartis
16-Dec-2020	OncoZenge expands the board with Hilde Furberg	Moberg Pharma
16-Dec-2020	KITE’S TECARTUS®▼ (AUTOLOGOUS ANTI-CD19-TRANSDUCED CD3+ CELLS) GRANTED CONDITIONAL MARKETING AUTHORISATION FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY INCLUDING A BRUTON’S TYROSINE KINASE (BTK) INHIBITOR	Kite, a Gilead Company
16-Dec-2020	Kallik’s Veraciti user data reveals major benefits from automated artwork and label management adoption in highly regulated industries	Kallik
16-Dec-2020	Teknova completes FDA notification for room temperature-stable viral transport medium	Teknova
16-Dec-2020	First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis	Fasenra
16-Dec-2020	Kantar Announces Agreement for Sale of Health Division to Cerner.	Kantar
16-Dec-2020	PharmiWeb.jobs Welcomes Albion Rye Associates	PharmiWeb.Jobs
15-Dec-2020	ABPI Board announces Kate Brunner QC appointed as new Chair of the PMCPA Appeal Board	ABPI
15-Dec-2020	Sensyne Health launches first digital health product in the U.S.	Sensyne Health
15-Dec-2020	Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia	Minoryx
15-Dec-2020	Air Cargo Industry Improves its Readiness to Transport COVID-19 Vaccines, but More Collaboration is Required	Pharma.Aero
15-Dec-2020	Seagen Announces Positive CHMP Opinion for Tucatinib for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer	Seagen Inc
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
15-Dec-2020	Primary care committed to Covid vaccine programme but needs support	NHS Confederation
15-Dec-2020	Polyphor announces third positive Data Safety Monitoring Board (DSMB) recommendation to continue Phase III balixafortide FORTRESS study without modifications	Polyphor AG